Series B - MabVax Therapeutics - Nov 20, 2012 Funding Round Profile - Cointime

Bitcoin $79,605.86 +4.25%
Ethereum $3,191.59 +5.04%
BNB $636.03 +2.03%
Optimism $1.67 +3.73%
Arbitrum $0.64 +5.09%
Solana $204.39 +2.03%
Polygon $0.41 +6.44%
Cosmos $5.34 +13.26%
Avalanche $32.10 +10.17%

Bitcoin $79,605.86 +4.25%
Ethereum $3,191.59 +5.04%
BNB $636.03 +2.03%
Optimism $1.67 +3.73%
Arbitrum $0.64 +5.09%
Solana $204.39 +2.03%
Polygon $0.41 +6.44%
Cosmos $5.34 +13.26%
Avalanche $32.10 +10.17%

MabVax Therapeutics

company

Funding Round

Series B

Money Raised

$ 5.25M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Numoda Capital Innovations	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 27, 2008	Series A	$ 8M	GBP Capital	Detail